Postbiotics, Inc. and Sabinsa have entered a multinational distribution agreement for the distribution of PoZibio, a postbiotic ingredient formulated for leaky gut syndrome (LGS). The agreement covers the U.S., Canada, European Union, India, Japan, and other markets.
 
PoZibio is a patented postbiotic composition of lipoteichoic acid from the cell walls of heat treated Lactobacillus paracasei. It was discovered by gut microbiome longevity researchers at Wake Forest University College of Medicine. The ingredient is suitable for functional foods, medical foods, and dietary supplements, and has a low efficacious dose, is heat stable, and has a neutral taste profile.
 
LGS increases with aging and is associated with occasional symptoms of irregularity, diarrhea, gas, bloating, fatigue, age-related cognitive decline, metabolic and muscle health, immune function, and decreased GLP-1 production.
 
“I’m pleased to bring forth an ingredient for a condition that is very under-addressed in the marketplace,” said Shaheen Majeed, global CEO and managing director of Sabinsa. “Additionally, this marks one of the very first partnerships Sabinsa enters into globally, and at its core represents the best of science and functionality.”

“We are pleased to be working with Sabinsa, and believe their global sales organization and manufacturing prowess are perfect complements to our world-class research,” said Doug Lynch, co-founding partner and chief commercial officer of Postbiotics, Inc. “This distribution partnership with Sabinsa will ensure consumer brands of supplements and foods in the United States and beyond will experience the many benefits from postbiotics on improving health and lifespan.”
 
“The gut-brain axis benefits we have shown from PoZibio are compelling. PoZibio has been shown to increase the mucus layer of the gut wall, inhibit age-related inflammation, support cognitive function, and promote muscle and metabolic health, in prior and ongoing research,” said Hariom Yadav, PhD, associate professor of neurosurgery and brain repair and director of the University of South Florida’s center for microbiome research, who discovered PoZibio.
 
PoZibio is GRAS and non-GMO.